Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy
Original Article
C. Touzeau, R. Mina, H. Quach, V. Hungria, D. Bhutani, W. Chen, S. Kumar, C. Chaulagain, M.A. Dimopoulos, N.J. Bahlis, S. Maral, N.W.v.d. Donk, J.S. Filho, K. Saja, R. Teipel, M. Ando, W. Roeloffzen, O. Annibali, B. Augustson, C. Botta, M. Delforge, E. Bourgeois, G. Buda, M. Hus, A. Perrot, M. Preis, M. Beksac, L. Pour, S. Farmer, M. Nunes, A. Oriol, T. Melchardt, Y. Hu, M. Flogegård, D. Wang, L. Pei, S. Wroblewski, I.M. Ariës, N.A.Q. Cardé, T. Perova, T.d. Jager, T.-M. Yeh, V. Vanquickelberghe, P. Shah, K. Chastain, R. Kobos, R. Carson, and O. Landgren
N Engl J Med 2026;395:440-453
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Please sign in or create an account to take the course.

Facebook
X
LinkedIn
Forward